Multimorbidity and frailty are associated with poorer
SARS-CoV-2-related outcomes: systematic review of
population-based studies

J 2024

Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies

MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ et. al.

Základní údaje

Originální název

Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies

Autoři

MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ (203 Česká republika, domácí), Barbora VASINOVA (203 Česká republika), Rodrigo FETEIRA-SANTOS, Peter BEZZEGH, Felipe Ponce BOLLMANN, James COTTAM, Romana HANEEF, Brecht DEVLEESSCHAUWER, Niko SPEYBROECK, Paulo Jorge NOGUEIRA, Maria Joao FORJAZ, Joel COSTE a Laure CARCAILLON-BENTATA

Vydání

AGING CLINICAL AND EXPERIMENTAL RESEARCH, NEW YORK, SPRINGER, 2024, 1594-0667

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.000 v roce 2022

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1007/s40520-023-02685-4

UT WoS

001161688700002

Klíčová slova anglicky

COVID-19; SARS-CoV-2; Multimorbidity; Multiple chronic conditions; Frailty

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 10. 6. 2024 12:18, Mgr. Tereza Miškechová

Anotace

V originále

BackgroundEstimating the risks and impacts of COVID-19 for different health groups at the population level is essential for orienting public health measures. Adopting a population-based approach, we conducted a systematic review to explore: (1) the etiological role of multimorbidity and frailty in developing SARS-CoV-2 infection and COVID-19-related short-term outcomes; and (2) the prognostic role of multimorbidity and frailty in developing short- and long-term outcomes. This review presents the state of the evidence in the early years of the pandemic. It was conducted within the European Union Horizon 2020 program (No: 101018317); Prospero registration: CRD42021249444.MethodsPubMed, Embase, World Health Organisation COVID-19 Global literature on coronavirus disease, and PsycINFO were searched between January 2020 and 7 April 2021 for multimorbidity and 1 February 2022 for frailty. Quantitative peer-reviewed studies published in English with population-representative samples and validated multimorbidity and frailty tools were considered.ResultsOverall, 9,701 records were screened by title/abstract and 267 with full text. Finally, 14 studies were retained for multimorbidity (etiological role, n = 2; prognostic, n = 13) and 5 for frailty (etiological role, n = 2; prognostic, n = 4). Only short-term outcomes, mainly mortality, were identified. An elevated likelihood of poorer outcomes was associated with an increasing number of diseases, a higher Charlson Comorbidity Index, different disease combinations, and an increasing frailty level.DiscussionFuture studies, which include the effects of recent virus variants, repeated exposure and vaccination, will be useful for comparing the possible evolution of the associations observed in the earlier waves.

Citovat

MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ, Barbora VASINOVA, Rodrigo FETEIRA-SANTOS, Peter BEZZEGH, Felipe Ponce BOLLMANN, James COTTAM, Romana HANEEF, Brecht DEVLEESSCHAUWER, Niko SPEYBROECK, Paulo Jorge NOGUEIRA, Maria Joao FORJAZ, Joel COSTE a Laure CARCAILLON-BENTATA. Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies. AGING CLINICAL AND EXPERIMENTAL RESEARCH. NEW YORK: SPRINGER, 2024, roč. 36, č. 1, s. 1-30. ISSN 1594-0667. Dostupné z: https://dx.doi.org/10.1007/s40520-023-02685-4.

@article{2409459,
   author = {Makovski, Tatjana T and Ghattas, Jinane and MonnierandBesnard, Stephanie and Cavillot, Lisa and Ambrožová, Monika and Vasinova, Barbora and FeteiraandSantos, Rodrigo and Bezzegh, Peter and Bollmann, Felipe Ponce and Cottam, James and Haneef, Romana and Devleesschauwer, Brecht and Speybroeck, Niko and Nogueira, Paulo Jorge and Forjaz, Maria Joao and Coste, Joel and CarcaillonandBentata, Laure},
   article_location = {NEW YORK},
   article_number = {1},
   doi = {http://dx.doi.org/10.1007/s40520-023-02685-4},
   keywords = {COVID-19; SARS-CoV-2; Multimorbidity; Multiple chronic conditions; Frailty},
   language = {eng},
   issn = {1594-0667},
   journal = {AGING CLINICAL AND EXPERIMENTAL RESEARCH},
   title = {Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies},
   url = {https://link.springer.com/article/10.1007/s40520-023-02685-4},
   volume = {36},
   year = {2024}
}

TY  - JOUR
ID  - 2409459
AU  - Makovski, Tatjana T - Ghattas, Jinane - Monnier-Besnard, Stephanie - Cavillot, Lisa - Ambrožová, Monika - Vasinova, Barbora - Feteira-Santos, Rodrigo - Bezzegh, Peter - Bollmann, Felipe Ponce - Cottam, James - Haneef, Romana - Devleesschauwer, Brecht - Speybroeck, Niko - Nogueira, Paulo Jorge - Forjaz, Maria Joao - Coste, Joel - Carcaillon-Bentata, Laure
PY  - 2024
TI  - Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies
JF  - AGING CLINICAL AND EXPERIMENTAL RESEARCH
VL  - 36
IS  - 1
SP  - 1-30
EP  - 1-30
PB  - SPRINGER
SN  - 15940667
KW  - COVID-19
KW  - SARS-CoV-2
KW  - Multimorbidity
KW  - Multiple chronic conditions
KW  - Frailty
UR  - https://link.springer.com/article/10.1007/s40520-023-02685-4
N2  - BackgroundEstimating the risks and impacts of COVID-19 for different health groups at the population level is essential for orienting public health measures. Adopting a population-based approach, we conducted a systematic review to explore: (1) the etiological role of multimorbidity and frailty in developing SARS-CoV-2 infection and COVID-19-related short-term outcomes; and (2) the prognostic role of multimorbidity and frailty in developing short- and long-term outcomes. This review presents the state of the evidence in the early years of the pandemic. It was conducted within the European Union Horizon 2020 program (No: 101018317); Prospero registration: CRD42021249444.MethodsPubMed, Embase, World Health Organisation COVID-19 Global literature on coronavirus disease, and PsycINFO were searched between January 2020 and 7 April 2021 for multimorbidity and 1 February 2022 for frailty. Quantitative peer-reviewed studies published in English with population-representative samples and validated multimorbidity and frailty tools were considered.ResultsOverall, 9,701 records were screened by title/abstract and 267 with full text. Finally, 14 studies were retained for multimorbidity (etiological role, n = 2; prognostic, n = 13) and 5 for frailty (etiological role, n = 2; prognostic, n = 4). Only short-term outcomes, mainly mortality, were identified. An elevated likelihood of poorer outcomes was associated with an increasing number of diseases, a higher Charlson Comorbidity Index, different disease combinations, and an increasing frailty level.DiscussionFuture studies, which include the effects of recent virus variants, repeated exposure and vaccination, will be useful for comparing the possible evolution of the associations observed in the earlier waves.
ER  -

MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ, Barbora VASINOVA, Rodrigo FETEIRA-SANTOS, Peter BEZZEGH, Felipe Ponce BOLLMANN, James COTTAM, Romana HANEEF, Brecht DEVLEESSCHAUWER, Niko SPEYBROECK, Paulo Jorge NOGUEIRA, Maria Joao FORJAZ, Joel COSTE a Laure CARCAILLON-BENTATA. Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies. \textit{AGING CLINICAL AND EXPERIMENTAL RESEARCH}. NEW YORK: SPRINGER, 2024, roč.~36, č.~1, s.~1-30. ISSN~1594-0667. Dostupné z: https://dx.doi.org/10.1007/s40520-023-02685-4.

Podrobný výpis o publikaci